GKOS: Q2 sales surged 50% year-over-year, led by iDose TR and Epioxa, with guidance raised to $680M–$700MQuartr·1 day ago, 05:57 PMGKOS+4.24%
Glaukos (NYSE:GKOS) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPSMarket Beat·1 day ago, 07:26 PMGKOS+4.24%
Glaukos Corp.’s Anti-Takeover Defenses Raise Governance Risk and Potentially Depress Shareholder ValueTip Ranks·4 hours agoGKOS+4.24%
Glaukos | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 185.61 MEarnings Watch·1 day ago, 03:22 PMGKOS+4.24%
Are UTZ, CRNX, SOLS Obtaining Fair Deals for their Shareholders?PR Newswire·2 days ago, 09:50 AMCRNX-0.30%SOLS+3.11%
Glaukos completes enrollment in 510(k) pivotal study of PRESERFLO MicroShunt for advanced glaucoma patientsPUBT·Jul 27 at 06:02 AMGKOS+4.24%
Moog partners with S3 AeroDefense to expand global access to avionics solutionsPUBT·Jul 21 at 03:46 AMMOG.A+7.54%
Krystal Biotech files patent response citing single-patient KB801 corneal closureTradingView·Jul 21 at 04:33 PMKRYS+0.98%
Portuguese Army selects Moog avionics to upgrade UH-60L helicopter fleetPUBT·Jul 21 at 02:49 AMMOG.A+7.54%
Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal PlansSimplywall·Jul 20 at 08:14 PMVRTX-0.34%CRNX-0.30%
